GlobeNewswire

Sanofi: Information concerning the total number of voting rights and shares – May 2026
15/06/2026
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]
Sanofi: Informations relatives au nombre de droits de vote et d'actions – Mai 2026
15/06/2026
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers Sanofi Société [...]
Major Shareholder Announcement
15/06/2026
Company Announcement Major shareholder announcement for Genmab A/S COPENHAGEN, Denmark; June 15, 2026 – Genmab A/S (Nasdaq: GMAB) announces under reference to Section 30 of the Danish Capital Markets Act that Orbis [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 24 - 2026
15/06/2026
Aggregated presentation by day and by market Purchases of own shares from June 8th to June 12th 2026 Name of the Issuer Identity code of the Issuer Day of the transaction Identity code of the financial instrument Total [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 24 - 2026
15/06/2026
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 8 juin au 12 juin 2026 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction Code [...]
IBA – ACQUISITION OF OWN SHARES
15/06/2026
Louvain-la-Neuve, Belgium, June 15 th , 2026 – 6 PM CEST – In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) [...]
IBA – ACQUISITION D’ACTIONS PROPRES
15/06/2026
Louvain-la-Neuve, Belgique, 15 juin 2026 – 18h00 – Conformément à l'article 8:4 de l'arrêté royal du 29 avril 2019 portant exécution du Code belge des sociétés et associations, Ion Beam Applications SA ("IBA") [...]
KFSH Demonstrates How Specialized Hospitals Can Drive Health System Innovation at HLTH Europe 2026
15/06/2026
AMSTERDAM, June 15, 2026 (GLOBE NEWSWIRE) -- Through its sponsorship and participation at HLTH Europe 2026, taking place from June 15 to 18 in Amsterdam, King Faisal Specialist Hospital & Research Centre (KFSH) is [...]
Le KFSH montre comment les hôpitaux spécialisés peuvent stimuler l’innovation au sein des systèmes de santé lors du congrès HLTH Europe 2026
15/06/2026
AMSTERDAM, 15 juin 2026 (GLOBE NEWSWIRE) -- À l’occasion de son parrainage et de sa participation au congrès HLTH Europe 2026, qui se tiendra du 15 au 18 juin à Amsterdam, le King Faisal Specialist Hospital & [...]
Zealand Pharma - Transactions related to share buy-back program (week 24, 2026)
15/06/2026
Company announcement No. 25 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 24, 2026) Copenhagen, Denmark, June 15, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: [...]
France Biotech to Showcase the Strength and Global Momentum of French HealthTech at BIO International Convention 2026 in San Diego
15/06/2026
Meet France Biotech and the French delegation at BIO International Convention 2026 – French Pavilion #3325. France Biotech to Showcase the Strength and Global Momentum of French HealthTech at BIO International [...]
Medicana Health Group Celebrates Two Major Recognitions in Capital Magazine’s CSR Research
15/06/2026
“Next Stop: Mammography” is ranked among Türkiye’s top 20 corporate social responsibility projects, while Medicana Health Group is listed among the top five companies in the Health category Photo: A coastal bicycle tour [...]
Applied Biologics Reports Statistically Significant Improvement in Wound Closure Outcomes in Updated Analyses of the CAMPX Randomized Controlled Trial Evaluating XWRAP®
15/06/2026
SCOTTSDALE, Ariz., June 15, 2026 (GLOBE NEWSWIRE) -- Applied Biologics, a biopharmaceutical company advancing novel biologic therapies for serious diseases with significant unmet medical needs, today announced positive [...]
Cardiawave Announces First Routine Treatments Performed with Valvosoft® Following CE Mark Approval and Accelerates Its Deployment
15/06/2026
Cardiawave Announces First Routine Treatments Performed with Valvosoft® Following CE Mark Approval and Accelerates Its Deployment After demonstrating its safety and performance in more than 100 patients during clinical [...]
Wildfire Smoke Reaches Record Levels as Americans Struggle to Breathe
15/06/2026
Betterbrand's BetterLungs supplement supports respiratory health naturally as wildfire season intensifies across the U.S. SAN ANTONIO, TX, June 15, 2026 (GLOBE NEWSWIRE) -- Wildfire Smoke Reaches Record Levels as [...]
Cuprina Receives U.S. FDA 510(k) Clearance for MEDIFLY Maggots — the First U.S. Clearance for a Lucilia cuprina Maggot Debridement Product
15/06/2026
SINGAPORE, June 15, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“ CUPR ” or “the Company ”), a biomedical company developing and marketing products for the chronic wounds, infertility, [...]
Cosmos Health Provides Update on United States Portfolio; Four 18 Series Products Introduced With Projected Annualized Revenue Over $22.7M and Approximately $17.0M Gross Profit
15/06/2026
Company at a Turning Point — Moving the Business to a Different Level, With Growing Revenue and a Roadmap Toward Improved Profitability CHICAGO, June 15, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or [...]
Cannabix Technologies Announces Deployment of Marijuana Breath Test (MBT) with Major Industrial Operator in Quebec
15/06/2026
VANCOUVER, British Columbia, June 15, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) developer of marijuana and alcohol breath testing [...]
ENDO 2026 Oral Presentation Highlights Comparative Clinical Data for Entera’s Breakthrough Single Tablet EB613 (First-in-Class Oral PTH(1-34) Anabolic for Osteoporosis)
15/06/2026
The pharmacokinetic (PK) and pharmacodynamic (PD) profiles of single tablet EB613, multi-tablet EB613 and Forteo® reported for the first time as an oral presentation at ENDO 2026 Single tablet EB613 achieved a [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum